Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

Pfizer

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Sponsoring "George Brett Ben-Gay Batting Challenge" to raise money for the Arthritis Foundation through the newly created George Brett Arthritis Fund. Pfizer is donating $ 100 to the Arthritis Foundation for every one of Brett's hits during the 1993 baseball season, $ 500 for every home run and $ 1,000 for every grand slam in the Kansas City Royals slugger's final season. Brett, who has done commercials for DayTime Ben-Gay, is featured in a new TV ad for Ultra Strength Ben-Gay that carries the tagline "Nothing's stronger".

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

NGGT Progresses First US Gene Therapy Trials For Rare Conditions

'We Are Not Waiting To Be Replaced': Medical Affairs Pros Take On GPT-4o

Japan Reimburses Zolbetuximab, To Cut Price Of Imfinzi, Others

Korea’s Clinical Trial Approvals Up 10%, But Still Below Pandemic Peak

See All
UsernamePublicRestriction

Register

PS082029

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By